MedNous Briefing: FDA policy on digital health
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Research Directory
The case for optimism for Europe's biotech sector
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundOrchard Therapeutics targets rare diseases
Interviewee/ContributorMark RotheraOrganisationOrchard TherapeuticsThe three waves of gene therapy
Interviewee/ContributorFrank SchniedersOrganisationProvecs Medical GmbHBuilding the next generation of gene transfer vectors
Interviewee/ContributorMichael L RobertsOrganisationSynpromics Ltd2017 Oncology Review: Global oncology drug approvals accelerate
Interviewee/ContributorBruno PagliaraOrganisationOn-kòs Pharma Consulting2017 stock market review: Biotechs buoyed by share issues
Interviewee/ContributorWilliam EllingtonOrganisationMedNousEurope's biotech entrepreneurs
Interviewee/ContributorVictoria EnglishOrganisationMedNousThe case for value-based pricing
Interviewee/ContributorTara RaveendranOrganisationShore CapitalBill Gates backs Alzheimer's disease research
Interviewee/ContributorJean-Claude MullerOrganisationMedNous Editorial Board